CAS: 1020172-07-9 - Rebastinib
Formula:C30H28FN7O3
- Synonyms:
- N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea
- Dcc-2036
2-Pyridinecarboxamide, 4-[4-[[[[3-(1,1-dimethylethyl)-1-(6-quinolinyl)-1H-pyrazol-5-yl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-
CAS:1020172-07-9
Formula:
C30H28FN7O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
553.5868
Ref: AN-AG0006BU
5mg | 67.00 € | |
10mg | 88.00 € | |
50mg | 168.00 € | |
100mg | 283.00 € | |
250mg | 636.00 € |
Estimated delivery in United States, on Monday 13 May 2024
Rebastinib
CAS:1020172-07-9
DCC-2036 (Rebastinib (DCC-2036)) is a conformational control Bcr-Abl inhibitor for Abl1(WT, IC50: 0.8 nM) and …
Formula:
C30H28FN7O3
Purity:
99.84%
Color and Shape:
Solid
Molecular weight:
553.59
Ref: TM-T2640
2mg | 47.00 € | |
5mg | 68.00 € | |
10mg | 94.00 € | |
25mg | 169.00 € | |
50mg | 247.00 € | |
100mg | 370.00 € | |
200mg | 557.00 € | |
1ml*10 (DMSO) | 83.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
DCC 2036
CAS:1020172-07-9
Inhibits multiple tyrosine kinases (Abl1, Src family kinases, Tie-2 and VEGFR-2)
Formula:
C30H28FN7O3
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
553.59 g/mol
Ref: 3D-FD64998
10mg | 107.00 € | |
50mg | 330.00 € | |
100mg | 496.00 € | |
250mg | 789.00 € | |
500mg | 1,053.00 € |
Estimated delivery in United States, on Wednesday 22 May 2024
Rebastinib
CAS:1020172-07-9
Applications Rebastinib shows the selectivity for growth inhibition of Bcr-Abl-positive cells by its marked inhibition …
Formula:
C30H28FN7O3
Color and Shape:
Off-White Solid
Molecular weight:
553.59
Ref: TR-R139300
1mg | 237.00 € | |
10mg | 707.00 € | |
2500µg | 517.00 € |
Estimated delivery in United States, on Friday 21 Jun 2024